Corporate and Social Responsibility Report

Overview

The report describes GSK's 2002 work to improve access to medicines in developing countries, including 66 million albendazole tablets donated to 31 countries and nearly 6 million Combivir tablets shipped at preferential prices. It reports £239 million in community investment and charitable contributions. It also describes company-wide EHS targets through 2005 and CSR management involving a cross-functional team and board CSR committee.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2002
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services